Low-Intensity Therapy in Adults with Burkitt's Lymphoma
Low-Intensity Therapy in Adults with Burkitt's Lymphoma
About this item
Full title
Author / Creator
Publisher
Waltham, MA: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
Waltham, MA: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
Toxic high-dose chemotherapy may not be necessary to cure Burkitt's lymphoma in adults and patients with immunodeficiency. An infusion-based chemotherapy program with modest toxicity administered mainly in outpatients resulted in an overall survival rate of 90 to 100%.
Burkitt's lymphoma, first described by Denis Burkitt in African children, is...
Alternative Titles
Full title
Low-Intensity Therapy in Adults with Burkitt's Lymphoma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3901044
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3901044
Other Identifiers
ISSN
0028-4793,1533-4406
E-ISSN
1533-4406
DOI
10.1056/NEJMoa1308392
